DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo
Keywords: DT-13 (PubChem CID: 101514160); Paclitaxel (PubChem CID: 36314); Carboplatin (PubChem CID: 38904); Cisplatin (PubChem CID: 441203); 5-Fluorouracil (PubChem CID: 3385); Topotecan (PubChem CID: 60700); DT-13; Topotecan (TPT); Drug combination; Gastric cance